M&A Deal Summary

EVERSANA Acquires The Access Group

On October 1, 2018, EVERSANA acquired marketing company The Access Group from Water Street Healthcare Partners

Acquisition Highlights
  • This is EVERSANA’s 1st transaction in the Marketing sector.
  • This is EVERSANA’s 3rd transaction in the United States.
  • This is EVERSANA’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2018-10-01
Target The Access Group
Sector Marketing
Buyer(s) EVERSANA
Sellers(s) Water Street Healthcare Partners
Deal Type Merger

Target

The Access Group

Berkeley Heights, New Jersey, United States
The Access Group is a provider of marketing and advertising services to pharmaceutical, biotechnology and other health care clients. The Access Group offers pharmaceutical companies specialized expertise and capabilities that define and communicate drug therapies' value proposition to payers; educate the medical community on new drugs; and create and execute strategies that brand and market their products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

EVERSANA

Milwaukee, Wisconsin, United States
Category Company
Sector Life Science
DESCRIPTION
EVERSANA's corporate headquarters in Milwaukee, Wisconsin.
EVERSANA's corporate headquarters in Milwaukee, Wisconsin.

EVERSANA combines global life science services into an integrated, independent and intelligent commercialization platform. With services rooted in the patient experience and spanning global pricing, market access, marketing, patient support, channel distribution, and consulting, the company creates value for patients, prescribers, and payers at all stages of the product lifecycle. EVERSANA is based in Milwaukee, Wisconsin.

DEAL STATS #
Overall 3 of 10
Sector (Marketing) 1 of 3
Type (Merger) 2 of 2
State (New Jersey) 1 of 1
Country (United States) 3 of 7
Year (2018) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 Triplefin

Cincinnati, Ohio, United States

Triplefin LLC is a provider of integrated business process outsourcing solutions to pharmaceutical and consumer products companies. Triplefin delivers comprehensive hub services that improve patient access and adherence, including its patent-pending Rx365® suite of digital solutions. Triplefin’s programs help thousands of patients with serious diseases, offering hope and improved well-being. Its associates are dedicated to providing an empathetic, caring experience throughout a patient’s journey. The company is headquartered in Cincinnati, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-30 Cornerstone Research Group

Burlington, Ontario, Canada

Cornerstone Research Group, Inc. is a global health economic and market access research company involved in developing evidence-based market access solutions. Cornerstone initially focused on health economics research with an emphasis on global cost-effectiveness models and Canadian reimbursement submissions. Cornerstone was formed in 2005 and is based in Burlington, Ontario.

Buy -

Seller(S) 1

SELLER

Water Street Healthcare Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Water Street is a specialist private equity firm that targets investments in healthcare companies. Specific areas of interest within healthcare include diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals, and specialty services. Water Street targets non-core units of larger corporations and private middle-market companies. Transactions are typically valued between $50 and $500 million. Water Street does not invest in biotechnology, traditional healthcare facilities (hospitals, nursing homes) or early-stage companies without positive cash flow. Water Street was formed in 2005 and is based in Chicago, Illinois.

DEAL STATS #
Overall 27 of 31
Sector (Marketing) 1 of 1
Type (Merger) 4 of 4
State (New Jersey) 3 of 4
Country (United States) 27 of 30
Year (2018) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 Triplefin

Cincinnati, Ohio, United States

Triplefin LLC is a provider of integrated business process outsourcing solutions to pharmaceutical and consumer products companies. Triplefin delivers comprehensive hub services that improve patient access and adherence, including its patent-pending Rx365® suite of digital solutions. Triplefin’s programs help thousands of patients with serious diseases, offering hope and improved well-being. Its associates are dedicated to providing an empathetic, caring experience throughout a patient’s journey. The company is headquartered in Cincinnati, Ohio.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-16 Discovery Life Sciences

Huntsville, Alabama, United States

Discovery Life Sciences is a provider of biospecimen analysis, procurement, distribution, and genomic, cell-based and histology-based scientific services for the pharmaceutical, biotechnology, and diagnostics industries. HudsonAlpha Discovery is Discovery’s sequencing and bioinformatics division, a globally recognized service laboratory that leverages the most current genomic research technologies to comprehensively support discovery, translational, and clinical research. Discovery Life Sciences was founded in 2018 and is based in Huntsville, Alabama.

Buy -
Mergr

Product

Company

Legal